S100B

S100B 詳細

英語名Protein Nef市販薬剤の数0
治験薬の数1ターゲットの別称nef,Negative factor,3'ORF,Protein Nef,F-protein
研究&開発段階Phase 1 Clinical
英語名Protein Nef
ターゲットの別称nef,Negative factor,3'ORF,Protein Nef,F-protein
市販薬剤の数0
治験薬の数1
研究&開発段階Phase 1 Clinical

S100B 製品リスト

  • 属性

    Protein (1)

  • 製品ライブラリ

    オンライン (1)

  • Human (1)

  • タグ

    His Tag (1)

  • マーカー

    Unconjugated (1)

製品番号発現システム製品説明タンパク質の構造純度特性
Human
E. coli
Human S100B Protein, His Tag
総数量1
  • 1

S100Bバックグランド

S-100 protein beta chain (S100B),a member of the S-100 family, is also known as S-100 protein subunit beta and S100 calcium-binding protein B, which contains two EF-hand domains. S100B can weakly bind calcium but bind zinc very tightly-distinct binding sites with different affinities exist for both ions on each monomer. Also, S100B can bind to and initiate the activation of STK38 by releasing autoinhibitory intramolecular interactions within the kinase. Interaction with AGER after myocardial infarction,S100B may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling. Fuethermore,S100B could assist ATAD3A cytoplasmic processing, preventing aggregation and favoring mitochondrial localization. S100B may mediate calcium-dependent regulation on many physiological processes by interacting with other proteins, such as TPR-containing proteins, and modulating their activity.

S100B分子の別称

S100B,NEF,S100,S100beta

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
HIV clade B mRNA dendritic cell therapy (Immunomic Therapeutics/Universite Libre de Bruxelles)Phase 1 ClinicalImmunomic Therapeutics IncHIV Infections
詳細
  • 詳細
  • 製品リスト
  • 治験薬に関する情報
お問い合わせ

お問い合わせ
グローバル:+1 800-810-0816(Toll Free)

メールアドレス
order.jp@acrobiosystems.com

アクロバイオシステムズ株式会社
〒101-0051
東京都千代田区神田神保町1-32-8